Yulia Lakhman1, Melvin D'Anastasi2,3, Maura Miccò4, Chiara Scelzo5, Hebert Alberto Vargas2, Stephanie Nougaret6,7, Ramon E Sosa2, Dennis S Chi8, Nadeem R Abu-Rustum8, Hedvig Hricak2, Evis Sala2. 1. Department of Radiology, Breast and Imaging Center, Memorial Sloan Kettering Cancer Center, 300 East 66 Street, New York, NY, USA. lakhmany@mskcc.org. 2. Department of Radiology, Breast and Imaging Center, Memorial Sloan Kettering Cancer Center, 300 East 66 Street, New York, NY, USA. 3. Institute for Clinical Radiology, University Hospitals Munich - Campus Grosshadern, Munich, Germany. 4. Department of Bioimaging and Radiological Science, Catholic University "A. Gemelli" Hospital, Rome, Italy. 5. Surgery Department, Gynecology and Obstetrics Section, Tor Vergata University, Rome, Italy. 6. Department of Imaging, CHU Montpellier, St. Eloi Hospital, Montpellier, France. 7. Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France. 8. Gynecologic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Abstract
PURPOSE: To determine if second-opinion review of gynaecologic oncologic (GynOnc) magnetic resonance imaging (MRI) by sub-specialized radiologists impacts patient care. METHODS: 469 second-opinion MRI interpretations rendered by GynOnc radiologists were retrospectively compared to the initial outside reports. Two gynaecologic surgeons, blinded to the reports' origins, reviewed all cases with discrepancies between initial and second-opinion MRI reports and recorded whether these discrepancies would have led to a change in patient management defined as a change in treatment approach, counselling, or referral. Histopathology or minimum 6-month imaging follow-up were used to establish the diagnosis. RESULTS: Second-opinion review of GynOnc MRIs would theoretically have affected management in 94/469 (20 %) and 101/469 (21.5 %) patients for surgeons 1 and 2, respectively. Specifically, second-opinion review would have theoretically altered treatment approach in 71/469 (15.1 %) and 60/469 (12.8 %) patients for surgeons 1 and 2, respectively. According to surgeons 1 and 2, these treatment changes would have prevented unnecessary surgery in 35 (7.5 %) and 31 (6.6 %) patients, respectively, and changed surgical procedure type/extent in 19 (4.1 %) and 12 (2.5 %) patients, respectively. Second-opinion interpretations were correct in 103 (83 %) of 124 cases with clinically relevant discrepancies between initial and second-opinion reports. CONCLUSIONS: Expert second-opinion review of GynOnc MRI influences patient care. KEY POINTS: • Outside gynaecologic oncologic MRI examinations are often submitted for a second-opinion review. • One-fifth of MRIs had important discrepancies between initial and second-opinion interpretations. • Second-opinion review of gynaecologic oncologic MRI is a valuable clinical service.
PURPOSE: To determine if second-opinion review of gynaecologic oncologic (GynOnc) magnetic resonance imaging (MRI) by sub-specialized radiologists impacts patient care. METHODS: 469 second-opinion MRI interpretations rendered by GynOnc radiologists were retrospectively compared to the initial outside reports. Two gynaecologic surgeons, blinded to the reports' origins, reviewed all cases with discrepancies between initial and second-opinion MRI reports and recorded whether these discrepancies would have led to a change in patient management defined as a change in treatment approach, counselling, or referral. Histopathology or minimum 6-month imaging follow-up were used to establish the diagnosis. RESULTS: Second-opinion review of GynOnc MRIs would theoretically have affected management in 94/469 (20 %) and 101/469 (21.5 %) patients for surgeons 1 and 2, respectively. Specifically, second-opinion review would have theoretically altered treatment approach in 71/469 (15.1 %) and 60/469 (12.8 %) patients for surgeons 1 and 2, respectively. According to surgeons 1 and 2, these treatment changes would have prevented unnecessary surgery in 35 (7.5 %) and 31 (6.6 %) patients, respectively, and changed surgical procedure type/extent in 19 (4.1 %) and 12 (2.5 %) patients, respectively. Second-opinion interpretations were correct in 103 (83 %) of 124 cases with clinically relevant discrepancies between initial and second-opinion reports. CONCLUSIONS: Expert second-opinion review of GynOnc MRI influences patient care. KEY POINTS: • Outside gynaecologic oncologic MRI examinations are often submitted for a second-opinion review. • One-fifth of MRIs had important discrepancies between initial and second-opinion interpretations. • Second-opinion review of gynaecologic oncologic MRI is a valuable clinical service.
Entities:
Keywords:
Cancer; Gynaecologic oncologic imaging; Magnetic resonance imaging; Second opinion; Subspecialty radiologists
Authors: William K Erly; Boyd C Ashdown; Richard W Lucio; Raymond F Carmody; Joachim F Seeger; Jennifer N Alcala Journal: AJR Am J Roentgenol Date: 2003-06 Impact factor: 3.959
Authors: Christian G Downs; Liz Fowler; Michael Kolodziej; Lee H Newcomer; Mohammed S Ogaily; W Thomas Purcell; John C Winkelmann; Clifford Goodman Journal: J Natl Compr Canc Netw Date: 2014-05 Impact factor: 11.908
Authors: P D Peppercorn; A R Jeyarajah; R Woolas; J H Shepherd; D H Oram; I J Jacobs; P Armstrong; D Lowe; R H Reznek Journal: Radiology Date: 1999-08 Impact factor: 11.105
Authors: Laurie A Loevner; Adina I Sonners; Brian J Schulman; Kerstin Slawek; Randal S Weber; David I Rosenthal; Gul Moonis; Ara A Chalian Journal: AJNR Am J Neuroradiol Date: 2002 Nov-Dec Impact factor: 3.825
Authors: Sharyl J Nass; Christopher R Cogle; James A Brink; Curtis P Langlotz; Erin P Balogh; Ada Muellner; Dana Siegal; Richard L Schilsky; Hedvig Hricak Journal: J Clin Oncol Date: 2019-05-03 Impact factor: 44.544
Authors: Renee A Cowan; Roisin E O'Cearbhaill; Ginger J Gardner; Douglas A Levine; Kara Long Roche; Yukio Sonoda; Oliver Zivanovic; William P Tew; Evis Sala; Yulia Lakhman; Hebert A Vargas Alvarez; Debra M Sarasohn; Svetlana Mironov; Nadeem R Abu-Rustum; Dennis S Chi Journal: Ann Surg Oncol Date: 2015-10-28 Impact factor: 5.344
Authors: Andrew B Rosenkrantz; Laura Chaves Cerdas; Danny R Hughes; Michael P Recht; Sharyl J Nass; Hedvig Hricak Journal: J Am Coll Radiol Date: 2020-07-05 Impact factor: 5.532
Authors: Vaios Hatzoglou; Antonio M Omuro; Sofia Haque; Yasmin Khakoo; Ian Ganly; Jung Hun Oh; Amita Shukla-Dave; Robin Fatovic; Joshua Gaal; Andrei I Holodny Journal: Cancer Date: 2016-05-24 Impact factor: 6.860